Erica L. Mayer is a medical oncologist at the Susan F. Smith Center for Women’s Cancers/Dana-Farber Cancer Institute, as well as an associate physician at Brigham & Women’s Hospital and assistant professor of medicine at Harvard Medical School. She’s the faculty education coordinator for breast oncology and director of advanced fellowship in breast oncology at Dana-Farber, as well as director of clinical research at Dana-Farber and Women’s Cancer Center at Faulkner Hospital. Mayer received a bachelor’s degree in both biology and history from Williams College in Williamstown, MA, where she graduated summa cum laude (1995). She received her MD from Harvard Medical School (2000), and her MPH in clinical effectiveness from Harvard School of Public Health (2005). Dr. Mayer’s postdoctoral training included a clinical fellowship at Harvard Medical School (2000-2006), a residency in internal medicine at Brigham & Women’s Hospital (2000-2003), a chief residency in internal medicine at Faulkner Hospital (2002-2006), and clinical fellowships in both medical oncology and medicine at Dana-Farber/Partners Cancer Care and Brigham & Women’s Hospital, respectively (2003-2006).
Dr. Mayer is a member of the Massachusetts Medical Society, American Society of Clinical Oncology, Cancer and Leukemia Group B, and Translational Breast Cancer Research Consortium. She’s involved in numerous funded research projects focusing on the role of novel biologic agents in the treatment of advanced breast cancer, and she has been published in numerous peer-reviewed publications including Nature, Journal of Biological Chemistry, Clinical Breast Cancer, Journal of Clinical Oncology, American Journal of Surgery, Annals of Oncology, and Clinical Cancer Research.